236 related articles for article (PubMed ID: 15630853)
1. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
Biswas S; Nik S; Corrie PG
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
[TBL] [Abstract][Full Text] [Related]
2. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
Dahan L; Ressiot E; Cournede A; Ries P; Duluc M; Laquiere A; Laugier R; Braguer D; Seitz JF
Gastroenterol Clin Biol; 2007 Dec; 31(12):1143-5. PubMed ID: 18176375
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.
Baron D; Mayo A; Kluger Y
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):90-1. PubMed ID: 16477934
[No Abstract] [Full Text] [Related]
4. Gemcitabine-induced chronic systemic capillary leak syndrome.
Bajwa R; Starr J; Daily K
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855215
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-induced systemic capillary leak syndrome.
De Pas T; Curigliano G; Franceschelli L; Catania C; Spaggiari L; de Braud F
Ann Oncol; 2001 Nov; 12(11):1651-2. PubMed ID: 11822767
[TBL] [Abstract][Full Text] [Related]
6. Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.
Spanos S; Vourliotaki I; Drossitis I; Tsoussis S
J BUON; 2009; 14(4):728-9. PubMed ID: 20148474
[No Abstract] [Full Text] [Related]
7. In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways.
Wu W; Xia Q; Luo RJ; Lin ZQ; Xue P
Asian Pac J Cancer Prev; 2015; 16(10):4369-76. PubMed ID: 26028101
[TBL] [Abstract][Full Text] [Related]
8. Severe acute lung injury induced by gemcitabine.
Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
[TBL] [Abstract][Full Text] [Related]
9. Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease.
Casadei Gardini A; Aquilina M; Oboldi D; Lucchesi A; Carloni S; Tenti E; Burgio MA; Amadori D; Frassineti GL
BMC Cancer; 2013 Nov; 13():542. PubMed ID: 24215543
[TBL] [Abstract][Full Text] [Related]
10. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
11. Congestive heart failure secondary to gemcitabine nab-paclitaxel in patients with pancreatic cancer.
John P; Butler H; Saif MW
Anticancer Res; 2014 Dec; 34(12):7267-70. PubMed ID: 25503159
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
Vander Els NJ; Miller V
Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
14. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
15. Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report.
Pulkkanen K; Kataja V; Johansson R
J Chemother; 2003 Jun; 15(3):287-9. PubMed ID: 12868557
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.
Bramhall SR; Schulz J; Nemunaitis J; Brown PD; Baillet M; Buckels JA
Br J Cancer; 2002 Jul; 87(2):161-7. PubMed ID: 12107836
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
Wolff RA; Evans DB; Gravel DM; Lenzi R; Pisters PW; Lee JE; Janjan NA; Charnsangavej C; Abbruzzese JL
Clin Cancer Res; 2001 Aug; 7(8):2246-53. PubMed ID: 11489798
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Alberts SR; Schroeder M; Erlichman C; Steen PD; Foster NR; Moore DF; Rowland KM; Nair S; Tschetter LK; Fitch TR
J Clin Oncol; 2004 Dec; 22(24):4944-50. PubMed ID: 15611509
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine and cancer of the pancreas: new preparation. Helpful or not?
Prescrire Int; 1999 Jun; 8(41):74-5. PubMed ID: 10558444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
